a numerical trendp=0.400
PAC use was not significantly associated with survival in this study, despite a numerical trend toward better outcome (p=0.400, Table 5 , Figure S4 ).
PAC use was not significantly associated with survival in this study, despite a numerical trend toward better outcome (p=0.400, Table 5 , Figure S4 ).
A suggestive trend of improving 30‐day survival was observed (56.8%, 63.9%, and 72.2% in successive one thirds, P1, P2, and P3 of patients), paralleling a similar trend in achievement of best practices.
Additionally, variations in baseline characteristics and shock profiles over time could have influenced patient survival, even though these variations did not reach statistical significance.